[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556078":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":31,"responsibleParty":55,"collaborators":20,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":20,"eligibilityCriteria":62,"healthyVolunteers":59,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":20,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":20,"overallStatus":33,"whyStopped":20,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Chang Gung Memorial Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Short vitrector group","EXPERIMENTAL","All enrolled patients will receive vitrectomy with the 18 mm short vitrectomy probe (25+ Short TOTALPLUS Vit Pak, 7500 CPM, Str Endoillum. w\u002F RFID, Alcon Laboratories Inc., Fort Worth, TX, USA.) for various vitreoretinopathies.",[13],"Device: Pars plana vitrectomy with a 18 mm short vitrector",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Pars plana vitrectomy with a 18 mm short vitrector","Using the shorter 18 mm vitrector for various pediatric vitreoretinal surgeries",[9],null,[22],{"name":23,"affiliation":24,"role":25},"Wei-Chi Wu, MD, PhD","Chang Gung Medical Foundation","STUDY_CHAIR",[27],{"name":23,"role":28,"phone":29,"phoneExt":20,"email":30},"CONTACT","886975365848","weichi666@gmail.com",[32],{"facility":5,"status":33,"city":34,"state":20,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Taoyuan","333","Taiwan","TW",{"type":39,"coordinates":40},"Point",[41,42],121.29696,24.99368,{"lat":42,"lon":41},[45,46,48,50,53],{"name":23,"role":28,"phone":29,"phoneExt":20,"email":30},{"name":23,"role":47,"phone":20,"phoneExt":20,"email":20},"PRINCIPAL_INVESTIGATOR",{"name":49,"role":47,"phone":20,"phoneExt":20,"email":20},"Hung-Da Chou, MD",{"name":51,"role":52,"phone":20,"phoneExt":20,"email":20},"Yih-Shiou Hwang, MD, PhD","SUB_INVESTIGATOR",{"name":54,"role":52,"phone":20,"phoneExt":20,"email":20},"Kuan-Jen Chen, MD",{"type":56,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100556078","phase-4-safety-and-efficacy-of-18-mm-short-vitrectomy-probe-for-pediatric-vitreoretinal-surgeries-100556078",false,"NCT06520410","Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries","Inclusion Criteria:\n\n* Patients less than 18 years old\n* Need vitrectomy due to various etiologies, including retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, congenital cataract, lens dislocation, open-globe injury, vitreous hemorrhage, or other vitreoretinal diseases.\n\nExclusion Criteria:\n\n* Patients who cannot cooperate fully with detailed ophthalmic examinations.","ALL","0 Years","18 Years",{"count":67,"type":68},60,"ESTIMATED","INTERVENTIONAL",[71],"PHASE4","This study aims to study the safety and efficacy of using an 18 mm short vitrectomy probe for pediatric vitreoretinal surgeries and to investigate the surgeon's comfort and reliability of using the shorter probe.",[74,75,76,77,78,79,80,81,82],"Retinopathy of Prematurity Both Eyes","Retinal Disease","Persistent Fetal Vasculature","Coats Disease","Coats Retinopathy","Familial Exudative Vitreoretinopathies","Vitreous Disorder","Vitreous Anomalies","Retinal Vascular Disorder","2024-07-21",{"date":85,"type":86},"2024-07-25","ACTUAL",{"date":88,"type":86},"2024-03-05",{"date":90,"type":68},"2028-02-28",{"name":5,"class":6},1]